aclidinium vs ciclesonide
Side-by-side comparison of aclidinium and ciclesonide Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Tudorza Pressair
Alvesco
Duaklir Pressair is a combination medicine used to help people with COPD breathe better. It contains two medicines that open up the airways in your lungs.
Omnaris Nasal Spray is a medicine that helps treat nasal allergy symptoms. It contains a corticosteroid to reduce inflammation in your nose.
Duaklir Pressair is used to treat chronic obstructive pulmonary disease (COPD). COPD is a long-term lung disease that makes it hard to breathe. This medicine helps to open the airways and make it easier to breathe for people with COPD.
Omnaris Nasal Spray treats nasal symptoms from seasonal allergies in adults and kids 6 years and older. It also treats year-round allergy symptoms in adults and teens 12 years and older. It helps relieve stuffy nose, runny nose, and sneezing.
Duaklir Pressair contains two medicines that work in different ways. One medicine relaxes the muscles around your airways, opening them up. The other medicine prevents the muscles from tightening.
Omnaris contains ciclesonide, a corticosteroid. It works by reducing inflammation in your nasal passages. This helps to relieve allergy symptoms like congestion and runny nose.
- • Upper respiratory infection
- • Headache
- • Back pain
- • Headache
- • Nosebleeds
- • Common cold
- • Ear pain
- • Throat pain
- Difficulty breathing 1,869
- Inhaler not working correctly 1,281
- Skipped a dose of medicine 1,017
- Asthma 814
- Chronic obstructive pulmonary disease (COPD) 764
- Asthma 5,711
- Shortness of breath 4,479
- Wheezing 3,589
- Medicine not fully working 2,550
- Cough 2,484
LABAs, such as formoterol fumarate, one of the active ingredients in DUAKLIR PRESSAIR, increase the risk of asthma-related death. Duaklir Pressair is not for asthma. Do not use Duaklir Pressair if you are allergic to milk proteins or any of the ingredients in it. Tell your doctor if you have heart problems, glaucoma, trouble urinating, diabetes, or seizures.
Omnaris may cause nosebleeds or Candida (fungal) infections in the nose. It could cause a hole in the nasal septum, or slow wound healing. It may also increase the risk of glaucoma or cataracts. Tell your doctor if you have vision changes or a history of eye problems. Omnaris may worsen existing infections like tuberculosis, herpes, or chickenpox. High doses can cause hormone and adrenal problems. It may slow down growth in children, so growth should be monitored.
It is not known if Duaklir Pressair will harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if this medicine passes into breast milk. Talk to your doctor about the best way to feed your baby if you are taking Duaklir Pressair.
There is not enough information about Omnaris use in pregnant women. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if Omnaris passes into breast milk.
Also Compare — Nearby Drugs
Compare aclidinium with
Compare ciclesonide with
How to Read This aclidinium vs ciclesonide Comparison
aclidinium is classified in the Long-Acting Muscarinic Antagonist (LAMA) drug class, while ciclesonide sits within the Inhaled Corticosteroid class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, aclidinium has 5,745 submissions while ciclesonide has 18,813. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between aclidinium and ciclesonide — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.